| Literature DB >> 27734948 |
Yingna Xing1,2, Xijuan Chen1, Xin Chen1, Jie Zhuang1,3.
Abstract
Pharmaceutical and personal care products (PPCPs) enter soils through reclaimed water irrigation and biosolid land applications. Colloids, such as clays, that are present in soil may interact with PPCPs and thus affect their fate and transport in the subsurface environment. This study addresses the influence of soil colloids on the sorption and transport behaviors of PPCPs through laboratory column experiments. Results show that the affinities of PPCPs for colloids vary with their molecular chemistry and solution ionic strength. The presence of colloids promotes the breakthrough of ciprofloxacin (over 90% sorbed on colloids) from ~4% to 30-40%, and the colloid-facilitated effect was larger at lower ionic strength (e.g., 2 mM). In comparison, the net effect of colloids on the transport of tetracycline (~50% sorbed on colloids) could be facilitation or inhibition, depending on solution chemistry. This dual effect of colloids is primarily due to the opposite response of migration of dissolved and colloid-bound tetracycline to the change in solution ionic strength. Colloids could also facilitate the transport of ibuprofen (~10% sorbed on colloids) by ~50% due likely to exclusion of dispersion pathways by colloid straining. This study suggests that colloids are significant carriers or transport promoters of some PPCPs in the subsurface environment and could affect their off-site environmental risks.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27734948 PMCID: PMC5062131 DOI: 10.1038/srep35407
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Structure and physicochemical properties of target PPCPs.
Physicochemical properties of colloid and sand.
| Materials | OM | CEC | Fed |
|---|---|---|---|
| % | cmol/kg | g/kg | |
| Colloid | 1.14 | 48.1 | 16.5 |
| Sand | − | 0.01 | — |
aOrganic matter content determined by potassium dichromate oxidation method50.
bCation exchange capacity at pH 7 determined by ammonium acetate method51.
cFree Fe oxide content measured by citrate–bicarbonate–dithionite method52.
dNot detected.
Experimental conditions of experimental columns.
| Ionic strength | Colloid | Bulk density | Soil porosity | Darcy velocity |
|---|---|---|---|---|
| mM | mg/L | g/cm | % | cm/h |
| 2 | 0 | 1.54 ± 0.01 | 42 | 12.6 ± 0.04 |
| 2 | 100 | 1.54 ± 0.01 | 42 | 12.5 ± 0.05 |
| 10 | 0 | 1.53 ± 0.01 | 42 | 12.5 ± 0.09 |
| 10 | 100 | 1.54 ± 0.01 | 42 | 12.4 ± 0.04 |
Figure 1Sorption kinetics of PPCPs on colloids and sand. Symbols and lines represent measurement and simulation using the pseudo-second-order equation.
CIP, ciprofloxacin; TC, tetracycline; IBU, ibuprofen.
K d values and sorption of PPCPs on sand and colloids after 24-hour equilibrium.
| PPCP | 2 mM | 10 mM | ||||||
|---|---|---|---|---|---|---|---|---|
| Equilibrium sorption (mg/kg) | Equilibrium sorption (mg/kg) | |||||||
| Colloid | Sand | Colloid | Sand | Colloid | Sand | Colloid | Sand | |
| CIP | 79,047 ± 2,357 | 7.1 ± 0.33 | 17,600 ± 70 | 6.1 ± 0.11 | 71,759 ± 2,175 | 4.7 ± 0.23 | 17,500 ± 70 | 5.1 ± 0.11 |
| TC | 10,035 ± 155 | 4.2 ± 0.77 | 10,500 ± 70 | 4.5 ± 0.42 | 7,033 ± 104 | 1.9 ± 0.07 | 8,600 | 2.8 ± 0.07 |
| IBU | 390 ± 38 | 0.28 ± 0.02 | 750 ± 70 | 0.53 ± 0.04 | 443 ± 38 | 0.24 ± 0.04 | 850 ± 70 | 0.45 ± 0.07 |
Mean values ± standard errors are presented. CIP, ciprofloxacin; TC, tetracycline; IBU, ibuprofen.
Figure 2Breakthrough of bromide and colloids from sand under saturated flow conditions.
Symbols and lines represent measurement and model fitting, respectively.
Transport parameters, maximum relative concentration (max C/C0), and recovery rate.
| Parameter | 2 mM without colloid | 2 mM with colloid | |||||
|---|---|---|---|---|---|---|---|
| CIP | TC | IBU | CIP | TC | IBU | Colloid | |
| katt1 (min−1) | 2.41E-01 ± 5.86E-02 | 5.80E-02 ± 1.33E-02 | 5.32E-02 ± 5.18E-03 | 2.15E-01 ± 6.77E-02 | 5.09E-02 ± 1.05E-02 | 2.20E-01 ± 6.03E-02 | 1.59E-01 ± 1.24E-02 |
| kdet1 (min−1) | 2.69E-02 ± 2.44E-02 | 6.41E-04 ± 7.34E-04 | 6.24E-03 ± 6.79E-04 | 3.48E-01 ± 9.60E-02 | 3.22E-02 ± 1.19E-02 | 2.88E-01 ± 6.90E-02 | 1.92E-01 ± 1.44E-02 |
| katt2 (min−1) | 8.46E-01 ± 1.89E-03 | 1.79E-01 ± 5.92E-02 | 1.74E-01 ± 4.82E-02 | 2.13E-01 ± 1.89E-03 | 1.45E-01 ± 9.7E-03 | 2.41E-02 ± 2.11E-03 | 1.73E-01 ± 1.53E-03 |
| R2 | 0.885 | 0.924 | 0.923 | 0.976 | 0.950 | 0.983 | 0.979 |
| max C/C0 | 0.07 ± 0.01 | 0.37 ± 0.01 | 0.57 ± 0.02 | 0.45 ± 0.01 | 0.41 ± 0.01 | 0.94 ± 0.02 | 0.52 ± 0.02 |
| recovery (%) | 3.87 ± 0.01 | 24.1 ± 0.18 | 59.7 ± 0.93 | 39.5 ± 0.08 | 31.4 ± 0.57 | 88.5 ± 1.7 | 44.2 ± 1.13 |
| Parameter | 10 mM without colloid | 10 mM with colloid | |||||
| CIP | TC | IBU | CIP | TC | IBU | Colloid | |
| katt1 (min−1) | 2.85E-01 ± 2.86E-02 | 3.45E-02 ± 1.60E-03 | 4.87E-02 ± 1.57E-03 | 2.13E-01 ± 4.79E-02 | 1.23E-01 ± 3.27E-02 | 1.75E-01 ± 2.92E-02 | 2.08E-01 ± 2.24E-02 |
| kdet1 (min−1) | 2.23E-02 ± 1.77E-02 | 1.55E-03 ± 7.46E-04 | 4.28E-03 ± 4.51E-04 | 2.86E-01 ± 5.32E-02 | 9.57E-02 ± 2.41E-02 | 1.79E-01 ± 2.62E-02 | 3.08E-01 ± 3.35E-02 |
| katt2 (min−1) | 7.76E-01 ± 1.64E-01 | 1.17E-01 ± 9.15E-03 | 2.17E-01 ± 2.05E-01 | 2.60E-01 ± 1.29E-03 | 1.39E-01 ± 2.33E-03 | 2.77E-02 ± 1.54E-03 | 2.23E-01 ± 7.98E-04 |
| R2 | 0.873 | 0.948 | 0.931 | 0.992 | 0.985 | 0.986 | 0.995 |
| Max C/C0 | 0.09 ± 0.01 | 0.54 ± 0.03 | 0.55 ± 0.03 | 0.38 ± 0.01 | 0.41 ± 0.03 | 0.93 ± 0.01 | 0.41 ± 0.03 |
| Recovery (%) | 3.92 ± 0.02 | 35.4 ± 0.45 | 57.0 ± 1.27 | 30.6 ± 0.11 | 33.5 ± 0.27 | 85.1 ± 1.37 | 35.8 ± 0.8 |
Mean values ± standard errors are presented. k att1, the first-order retention coefficient on Type 1 site; kdet1, the first-order detachment coefficient on the Type 1 site; katt2, the first-order detachment coefficient on the Type 2 site; R2, Person’s squared correlation coefficient; CIP, ciprofloxacin; TC, tetracycline; IBU, ibuprofen.
Figure 3Breakthrough of total PPCPs from sand columns.
Symbols and lines represent measurement and model fitting, respectively. CIP, ciprofloxacin; TC, tetracycline; IBU, ibuprofen.